• Sponsored Content

Anticipating Success: Meeting the Inherent Challenges of Complex Drug Substances

BPI Contributor

October 1, 2013

1 Min Read
Anticipating Success: Meeting the Inherent Challenges of Complex Drug Substances

Already have an account?


Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages.
A careful, systematic approach to identifying where and why these roadblocks can occur is fundamental to staying on course. Just as important is a robust, repeatable process design focused on retaining the stability of a compound as it moves through clinical development. The early-stage data captured during this period can play a valuable role in an efficient transition from lab to clinic to market.
Learn more about current market trends; get insights what might be roadblocks to a successful drug development and get practical solutions to meet the challenges of filling complex compounds.

You May Also Like